MedPath

Alaxia SAS

Alaxia SAS logo
🇫🇷France
Ownership
Private
Established
2008-01-01
Employees
-
Market Cap
-
Website
http://www.alaxia-pharma.eu

Dose Finding Study of STR-324

Phase 2
Conditions
Pain, Acute
Interventions
First Posted Date
2020-10-12
Last Posted Date
2021-07-13
Lead Sponsor
Alaxia SAS
Target Recruit Count
118
Registration Number
NCT04582786
Locations
🇳🇱

Leiden University Medical Center, Leiden, Netherlands

Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients

Phase 1
Terminated
Conditions
Cystic Fibrosis
Bronchiectasis
Interventions
Drug: OSCN-
Drug: bLF
Drug: Placebo
First Posted Date
2015-11-06
Last Posted Date
2022-02-03
Lead Sponsor
Alaxia SAS
Target Recruit Count
92
Registration Number
NCT02598999
Locations
🇫🇷

Eurofins Optimed, Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath